Results 141 to 150 of about 4,766,757 (295)

EGFR‐STAT3 activation provides a therapeutic rationale for targeting aggressive ETV1‐positive prostate cancer

Molecular Oncology, EarlyView.
Cotargeting EGFR and STAT3 with Erlotinib and TTI‐101 impairs both 2D and 3D growth of ETV1‐overexpressing prostate cancer cells by disrupting a self‐sustaining ETV1–EGFR positive feedback loop that promotes EGFR and STAT3 expression and phosphorylation (activation).
Elsa Gomes Paiva, Bernardo Orr, Ana Azeredo, Andreia Brandão, Manuel R. Teixeira, Paula Paulo   +5 more
wiley   +1 more source

Monitoring technology for pest-plant interactions : The need for transdisciplinary research design. [PDF]

EMBO Rep
Cavazzoni E, Leonelli S, Giannetti D, Patelli N, Vaccari G, Maistrello L, Pinotti MC.   +6 more
europepmc   +1 more source

How to use the Surveillance, Epidemiology, and End Results (SEER) data: research design and methodology. [PDF]

Mil Med Res, 2023
Che WQ, Li YJ, Tsang CK, Wang YJ, Chen Z, Wang XY, Xu AD, Lyu J.   +7 more
europepmc   +1 more source

3140) Research on Apartment House for Rice Growing Families : Part III(Environmental Engineering, Design and Planning)

, 1964
Yoshihiko Sasaki, Yoichiro Ezaki, Tsuneo Kajiura   +2 more
openalex   +2 more sources

Cytomegalovirus infection is common in prostate cancer and antiviral therapies inhibit progression in disease models

Molecular Oncology, EarlyView.
Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon, Moa Stenudd, Margherita Zamboni, Kanar Alkass, Carl‐Johan Eriksson, Lars Pedersen, Alrik Schörling, Anna Thoss, Anders Bergh, Pernilla Wikström, Hans‐Olov Adami, Henrik Toft Sørensen, Henrik Druid, Jonas Frisén   +13 more
wiley   +1 more source

The Internalized Ableism Inventory: Scale development using a hybrid artificial intelligence and community-based participatory research design. [PDF]

Rehabil Psychol
Perrin PB, Christ BR, Vargas TA, Dini ME, Ertman B, Cull SL, Rivera D, Xia B, Andrews-Ash EE, Mona L, Gates AJ, Klyce DW.   +11 more
europepmc   +1 more source

4097 Research on the Public Library(Design and Planning)

, 1967
Toshiaki Esaka
openalex   +2 more sources

Integrative miRNOMe profiling reveals the miR‐195‐5p–CHEK1 axis and its impact on luminal breast cancer outcomes

Molecular Oncology, EarlyView.
In luminal (ER+) breast carcinoma (BC), miRNA profiling identified miR‐195‐5p as a key regulator of proliferation that targets CHEK1, CDC25A, and CCNE1. High CHEK1 expression correlates with worse relapse‐free survival after chemotherapy, especially in patients with luminal A subtype.
Veronika Boušková, Marie Ehrlichová, Alžběta Spálenková, Ivona Krus, Simona Šůsová, Viktor Hlaváč, Vlasta Němcová, Renata Koževnikovová, Markéta Trnková, David Vrána, Jiří Gatěk, Kateřina Kopečková, Marcela Mrhalová, Soňa Měšťáková, Pavel Souček   +14 more
wiley   +1 more source

Developing the evidence-base to inform policy on inclusive research design. [PDF]

R Soc Open Sci
Child SA, Mulligan C, Pavlov I, Bryan S, Li L, Knowles RL.   +5 more
europepmc   +1 more source

Outcome of interventions to improve the quality of intrapartum care in Nigeria's referral hospitals: a quasi-experimental research design. [PDF]

BMC Pregnancy Childbirth, 2023
Okonofua F, Ntoimo LF, Ekezue B, Ohenhen V, Agholor K, Imongan W, Ogu R, Galadanci H.   +7 more
europepmc   +1 more source